NCT01051622View on ClinicalTrials.gov

PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Crohn's Disease
Interventions
OTHER

Labeling Ceretec

Technetium-99m is used to radiolabel cells of interest i.e PBMC's

Trial Locations (2)

3000

GSK Investigational Site, Leuven

1105 AZ

GSK Investigational Site, Amsterdam

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY